Bristol-Myers Squibb and AstraZeneca Announce ONGLYZA When Added to Insulin in Adults with Type 2 Diabetes Maintained Reductions in Blood Sugar Levels Over 52 Weeks in Investigational Study Extension
Eddie Staley